By Wayne Kuznar Compliance with treat-to-target guidelines for rheumatoid arthritis (RA) results in fewer inpatient visits, shorter lengths of stay, and lower utilization of emergency department services without additional medical service costs despite more frequent follow-up with a rheumatologist, found Martin J. Bergman, MD, FACR, FACP, Chief, Division of Rheumatology, Taylor Hospital, Ridley Park, PA, and colleagues.
By Phoebe Starr The goal of treating lupus is to induce improvement and maintain it, said Bevra Hahn, MD, Chief, Department of Rheumatology and Arthritis, University of California at Los Angeles.
By Phoebe Starr Tofacitinib (Xeljanz), an oral Janus kinase (JAK) inhibitor, is effective in the treatment of patients with rheumatoid arthritis (RA) whose disease has an inadequate response to previous treatment with biologic therapies, and the response with tofacitinib is maintained for 24 months.
Page 3 of 3
Results 21 - 23 of 23
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology